Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.067 | 0.7 |
mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.017 | 0.7 |